Satellite data reveals how rapidly and markedly the harmful compounds polluting our atmosphere drop off when humanity grinds to a halt. The ongoing pandemic lockdown highlights just how much our industrialized areas contribute to air pollution problems, but what lessons can be learnt?READ MORE
Testing the right person is a crucial aspect in any pandemic. Apart from saving lives, widespread testing can provide important data required to model the course of the outbreak. Reagents are a critical component of testing. Unfortunately, many US labs have struggled to procure the reagents needed to perform large batches of coronavirus diagnostic testing.
The lab of Dr Changchun Liu at the University of Connecticut Health Center is developing a simple, low-cost, CRISPR-based method which can detect infectious diseases such as COVID-19. Technology Networks spoke to Dr Liu to learn more about the method and the next steps to be taken before a point-of-care diagnostic test using it could become widely available.
Researchers from Queen’s University Belfast will screen approximately 1,000 drugs, which have already received regulatory approval for other indications, to ascertain if they can reduce virus infection or replication and virus-induced inflammatory responses in airway epithelial cell models and to determine if they can therefore be repurposed to treat COVID-19 patients.READ MORE
One in four people on earth are currently in lockdown related to the spread of the novel coronavirus SARS-CoV-2. In this article, we look at some expert advice at how to cope with the impacts of this isolation on your mental health.READ MORE
In the time of COVID-19, the Internet is aflush with expert advice about social distancing. At the same time, raw emotion has driven many to massive trips to the grocery store. In addition to toilet paper, alcohol-based hand sanitizer is the favorite on everybody’s panic-shopping list. The sale of hand sanitizers has gone up almost 500%, in contrast to soap, which has gone up a paltry 70%. So why do experts advise social distancing, and are hand sanitizers the answer to all our problems?READ MORE
Vivli, the Center for Clinical Research Data, recently issued a press release announcing the launch of the COVID-19 portal, designed to enable the sharing of completed interventional treatment trial data. Technology Networks spoke with Julie Wood, Vivli’s Director of Strategy and Operations, to learn more about the COVID-19 portal and discover how researchers can access the data within the portal.